A & W's Q4 2024 results reveal declining revenues but improved cost management. Click here to read more about AW:CA stock.

Reports a 73% improvement in YoY quarterly cashflow from operations and a 194% increase in YoY ARR.

Final analysis from IGNITE Phase 2 clinical trial planned for second quarter of 2025: The Company plans to report the final ...

Clear Secure's Q4 2024 earnings showed impressive growth, with revenues up 20.7%, free cash flow up 48%. See why I upgrade ...

AtkinsRéalis Group Inc. reported its fourth-quarter profit fell compared with a year ago as it announced the sale of its ...

The engineering services firm says it earned net income attributable to shareholders of $52.4-million or 30 cents per diluted ...

Results in Line with and Above Guidance RangesProvides 2025 GuidanceSAN FRANCISCO, March 11, 2025 (GLOBE NEWSWIRE) -- ...

Dorel Industries has reported a $73 million loss in the fourth quarter while revenue dropped and officials look to inject ...

Results of positron emission tomography (PET) trial and second multiple ascending dose (MAD-2) trial support RAP-219's transformative potential ...

Wall Street once again fixated on an earnings report from Nvidia, the main player in the artificial intelligence mania.

BlackSky Technology Inc. (“BlackSky” or the “Company”) (NYSE: BKSY) announced the successful Gen-3 launch and imaging ...